Superspreaders and lockdown timing explain the power law dynamics of COVID-19

Alexei Vazquez

doi:10.1101/2020.07.23.20160531

Abstract

Infectious disease outbreaks are expected to grow exponentially in time when left unchecked. Containment measures such as lockdown and social distancing can drastically alter the growth dynamics of the outbreak. This is the case for the 2019-2020 COVID-19 outbreak, which is characterized by a power law growth. Strikingly however, the power law exponent is different across countries. Here I illustrate the relationship between these two extreme scenarios, exponential and power law growth, based on the impact of superspreaders and lockdown strategies to contain the outbreak. The theory predicts a relationship between the power law exponent and the time interval between the first case and lockdown that is validated by the observed COVID-19 data across different countries.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by Cancer Research UK C596/A21140.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

The text has been edited. Some changes in notation.

Data Availability

All data is reported in the manuscript.

The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.